Dr. Dima Abdul Jabbar | Consultant Medical Oncologist in Abu Dhabi
About Us
Dr Dima Hospitals history
Discover the rich legacy and journey of our hospitals over the years. From our early days at St. John Providence Hospital to our current affiliation with Burjeel Cancer Institute, explore how each hospital shaped our commitment to world-class healthcare. Browse through the history with a detailed timeline, featuring key milestones and photos of each hospital to highlight their unique contributions to our mission of excellence in patient care.
- St. John Providence Hospital
- St. Joseph Hospital, Tampa
- University of Nevada, Las Vegas.
- American Hospital, Dubai
- Moffitt Cancer Center, Tampa
- Cleveland Clinic, Abu Dhabi
Dr Dima Work History
Follow-Up Protocol Table
| Risk Level | Imaging Plan | Clinical Review | Preventive Strategies |
|---|---|---|---|
| Moderate Risk (15–20%) | Annual mammogram + possibly ultrasound (US) | Annual | Lifestyle changes + possible chemoprevention |
| High Risk (>20–25%) | Annual mammogram and breast MRI | Every 6–12 months | Chemoprevention, lifestyle modifications, surgical counseling |
| Known Mutation Carrier | Annual MRI starting at age 25, mammogram from age 30 | Every 6 months | Strong consideration for prophylactic surgery |
| Year | Institution | Location |
|---|---|---|
| 2008–2011 | St. John Providence Hospital | Detroit, Michigan |
| 2011–2013 | University of Nevada | Las Vegas |
| 2013–2017 | Moffitt Cancer Center | Tampa, Florida |
| 2017–2019 | St. Joseph Hospital | Tampa, Florida |
| 2019–2021 | American Hospital | Dubai, United Arab Emirates |
| 2021–2025 | Cleveland Clinic | Abu Dhabi, United Arab Emirates |
| 2025–Present | Burjeel Cancer Institute | Abu Dhabi, United Arab Emirates |
Year
2008–2011
Institution
St. John Providence Hospital
Location
Detroit, Michigan
Year
2011–2013
Institution
University of Nevada
Location
Las Vegas
Year
2013–2017
Institution
Moffitt Cancer Center
Location
Tampa, Florida
Year
2017–2019
Institution
St. Joseph Hospital
Location
Tampa, Florida
Year
2019–2021
Institution
American Hospital
Location
Dubai, United Arab Emirates
Year
2021–2025
Institution
Cleveland Clinic
Location
Abu Dhabi, United Arab Emirates
Year
2025–Present
Institution
Burjeel Cancer Institute
Location
Abu Dhabi, United Arab Emirates
2008–2011
St. John Providence Hospital, Detroit, Michigan.
During her time at St. John Providence Hospital in Detroit, Michigan, Dr. Dima Abduljabbar honed her clinical expertise in oncology, providing exceptional care to a diverse patient population. At this hospital, she was part of a multidisciplinary team that delivered comprehensive cancer care, focusing on personalized treatment plans and the latest advancements in medical research. Her work at St. John Providence laid the foundation for her career, preparing her for the challenges and triumphs that would follow in her esteemed medical journey.
2011–2013
University of Nevada, Las Vegas
From 2011 to 2013, Dr. Abduljabbar joined the University of Nevada in Las Vegas where she expanded her research capabilities in cancer treatment and molecular biology. During this period, she contributed significantly to academic advancements in oncology, while also teaching and mentoring the next generation of medical professionals. This time in Las Vegas deepened her understanding of the complexities of cancer care and established her as a thought leader in the field.
2013–2017
Moffitt Cancer Center, Tampa, Florida
At Moffitt Cancer Center in Tampa, Florida, one of the nation’s top cancer hospitals, Dr. Abduljabbar worked on cutting-edge treatments and clinical trials. Here, she advanced her expertise in cancer research, focusing on innovative therapeutic methods for rare and aggressive cancers. Dr. Abduljabbar’s contributions were instrumental in improving patient outcomes, while also helping shape the future of cancer care through groundbreaking research.
2017–2019
St. Joseph Hospital, Tampa, Florida
From 2017 to 2019, Dr. Abduljabbar served at St. Joseph Hospital in Tampa, where she continued to refine her skills in cancer care, with a focus on integrating new technologies and treatments. During this period, she played a pivotal role in enhancing the hospital’s oncology department, ensuring that patients had access to the latest treatments and therapies. Her compassionate care and commitment to improving the quality of life for her patients earned her a stellar reputation within the Tampa community.
2019–2021
American Hospital, Dubai, United Arab Emirates
Dr. Abduljabbar’s move to the American Hospital in Dubai marked a significant milestone in her career. Between 2019 and 2021, she helped establish the hospital’s reputation as a leader in cancer care, leveraging both her expertise and the hospital’s state-of-the-art facilities. Her international experience allowed her to bring a global perspective to cancer treatment and research, influencing the way oncology care is delivered in the UAE.
2021–2025
Cleveland Clinic, Abu Dhabi, United Arab Emirates
Since 2021, Dr. Abduljabbar has been a key member of the Cleveland Clinic Abu Dhabi team. Known for its commitment to world-class medical care, Cleveland Clinic offers Dr. Abduljabbar the opportunity to provide cutting-edge treatment options in a multidisciplinary environment. Her work focuses on personalized cancer therapies and patient-centered care, ensuring that every individual receives the highest level of treatment available in the region.
2025–Present
Burjeel Cancer Institute, Abu Dhabi, United Arab Emirates
In 2025, Dr. Abduljabbar joined the Burjeel Cancer Institute in Abu Dhabi, a premier institution dedicated to cancer care. As a leading expert, she continues to shape the future of cancer treatment in the UAE, providing patients with access to the latest advances in oncology. Dr. Abduljabbar’s commitment to medical excellence and her passion for patient care make her an invaluable part of the Burjeel Cancer Institute’s esteemed team.
